Are you Dr. Alobeid?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
622 W 168th St
Ph 1564w
New York, NY 10032Phone+1 212-305-7399
Summary
- Dr. Bachir Alobeid, MD is a board certified pathologist in New York, New York. He is currently licensed to practice medicine in New York, California, and New Jersey. He is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center and New York-Presbyterian Hospital.
Education & Training
- University at Buffalo (Roswell Park Cancer Institute) Oncologic PathologyFellowship, Selective Pathology, 1996 - 1998
- Westchester Medical CenterResidency, Pathology-Anatomic and Clinical, 1994 - 1996
- Brooklyn Hospital CenterResidency, Pathology-Anatomic and Clinical, 1992 - 1994
- Damascus University Faculty of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 2006 - Present
- NY State Medical License 1998 - 2025
- NJ State Medical License 2005 - 2005
- MD State Medical License 1998 - 1998
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 6 citationsPrimary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement ...Andrew M. Parrott, Aya Haggiagi, Vundavalli V. Murty, Govind Bhagat, Bachir Alobeid
Hematological Oncology. 2020-07-08 - 55 citationsAggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement.Bachir Alobeid, Deborah W. Sevilla, Mahmoud El-Tamer, Vundavalli V. Murty, David G. Savage
Leukemia & Lymphoma. 2009-07-21 - 91 citationsTargeted next generation sequencing of breast implant‐associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3AArianna Di Napoli, Preti Jain, Enrico Duranti, Elizabeth Margolskee, Walter Arancio
British Journal of Haematology. 2018-03-01